Considering the importance of ZEB1 in EMT initiation and chemoresistance, our study indicates that FLASH-mediated ZEB1 regulation could be exploited to design therapies directed toward ZEB1 degradation in cells undergoing EMT to block this key step in cancer progression. The gene discussed is ZEB1; the disease is cancer.